Skip to main content

Innovation in Drugs is supplementing Growth in the Global Liquid Biopsy Market


According to Inkwood Research, the Global Liquid Biopsy Market is anticipated to register a CAGR of 20.50% in terms of revenue during the estimated period, 2020-2028.

“Browse 28 Market Data Tables and 67 Figures spread over 248 Pages, along with an in-depth TOC on the Global Liquid Biopsy Market Forecast 2020-2028.”


Liquid biopsy is emerging as an alternative to standard procedures for cancer screening. As a new type of blood test, liquid biopsy holds the potential to transform and enhance cancer treatment. It is projected that liquid biopsy, as a method of testing, will prove to be more effective and helpful in monitoring cancer medication and its status after diagnosis. Moreover, liquid biopsy is gaining rapid traction as a supplement for tissue biopsy for transplant medicine and reproductive health, in addition to cancer. 


Emergence of Tissue or Tumor-Agnostic Drugs Propagates Market Growth

The advent of tissue/tumor-agnostic drugs is a trend related to precision medicine. It targets genetic variants within cancer and propels the use of liquid biopsy diagnostics to identify distinctions. This phenomenon first occurred in May 2017, with the expanded approval of Merck’s drug, Keytruda (pembrolizumab) for patients with cancer, and microsatellite instability or mismatch repair deficiency. Numerous drug enterprises are presently following the same approval tactic that focuses on the genetic characteristics of the condition, instead of the organ where cancer originated.
To know more about this report, request a free sample copy.

Clinical Diagnostic Laboratories are the Major End-users

Clinical diagnostic laboratories are collaborating with firms that manufacture liquid biopsies, to lead the clinical laboratory solutions and systemization. Clinical diagnostic laboratories enable the diagnosis of colorectal cancer by screening samples collected from patients, typically from their homes. Additionally, the sale of liquid biopsy devices and other products is growing due to rising awareness regarding cancer and its corresponding non-surgical diagnostic methods. Tier-1 and Tier-2 diagnostic laboratories have an extensive network that enables easy accessibility and delivers quick results, within constrained time durations. Thus, the global authority of direct-to-consumer laboratories has assisted in adopting liquid biopsy tests and the sale of related merchandise.

North America is predicted to project Prominent Growth Rate by 2028

The demand for liquid biopsy in the North America region is predicted to increase across the forecast years, owing to the rising cancer cases. The United States and Canada have superior biopsy technologies, specially designed to identify diseases at early stages and substantially reduce fatalities. Moreover, the upsurge in healthcare expenditure by governments, is estimated to play a primary tole in fueling the demand for liquid biopsies in North America.

The industry rivalry within the emerging market is medium to intense, due to minimal factors restraining the entry of innovations and developments within the liquid biopsy market. Argon Medical Devices Inc, Planmeca OY, Becton Dickinson and Company (Bd), Agilent Technologies Inc, Bio-Rad Laboratories, etc. are among the prominent companies in the market.

About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.
Contact Us
https://www.inkwoodresearch.com
sales@inkwoodresearch.com
+1 857-302-4704
Related Reports:
GLOBAL BIOTECHNOLOGY REAGENTS MARKET
GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET
GLOBAL METASTATIC CANCER TREATMENT MARKET
GLOBAL CANCER BIOMARKER MARKET

Labels:

Comments

Post a Comment

Popular posts from this blog

Surging Chronic Conditions to Supplement Global Magnetic Resonance Imaging (MRI) Systems Market Growth

Inkwood Research anticipates that the Global Magnetic Resonance Imaging (MRI) Systems Market is evaluated to record a CAGR of 5.50% in terms of revenue during the forecasted years of 2021-2028. “Browse 53 Market Data Tables and 48 Figures spread over 229 Pages, along with an in-depth TOC on the Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2021-2028.”   BUY NOW - https://www.inkwoodresearch.com/reports/mri-systems-market/   Magnetic resonance imaging (MRI) is characterized as a non-invasive imaging technology aiming to produce detailed 3-D (three-dimensional) anatomical images. It is typically used for the detection and diagnosis of diseases, in addition to monitoring further treatment. MRI systems are based on a sophisticated technology that detects changes in the rotational axis direction of protons found in water that constitutes living tissues. Increasing Prevalence of Chronic Conditions to Augment Market Growth The four most critical types of chron
Post a Comment
Read more

Global Pharmacy Automation Equipment Market to Register Notable Growth Given the Decentralization of Pharmacies

Inkwood Research anticipates that the Global Pharmacy Automation Equipment Market is evaluated to project a CAGR of 7.93% in terms of revenue during the forecasting years of 2021-2028. “Browse 39 Market Data Tables and 39 Figures spread over 200 Pages, along with an in-depth TOC on the Global Pharmacy Automation Equipment Market Forecast 2021-2028.”   To know more about this report, request a free sample copy. Pharmacy automation is characterized as decentralized or centralized automated dispensing, labeling, packing, and other systems, that help minimize dispensing errors. Moreover, it also plays a vital role in terms of improving the workflow efficiency of hospital nursing staff as well as pharmacies. Decentralization of Pharmacies to Augment Market Growth Decentralized pharmacy services are considered in order to refer to a practice model where a pharmacist located on the ward is primarily responsible for distribution and clinical services, including possibly order entry
Post a Comment
Read more

Development of Target Based Drug Drives the Global Protein Sequencing Market at 6.47%

According to a new market research report published by Inkwood Research, Global Protein Sequencing Market is estimated to project a CAGR of 6.47% during the forecasting years of 2020-2028. "Browse 39 Market Data Tables and 44 Figures spread over 147 Pages, along with an in-depth TOC on the Global Protein Sequencing Market Forecast 2020-2028.” REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/protein-sequencing-market/#request-free-sample Protein sequencing provides information regarding the amino acids that constitute a protein. While the sequencing process is performed, amino acids are consecutively removed from the n-terminal end of the protein strand and identified in the order they occur in the protein. Growing Focus on Target-Based Drug Development Since the last few years, a growing number of findings based on proteomics have boosted innovative drug development. Moreover, many drugs have been developed with an emphasis on single protein target
Post a Comment
Read more